Chelsea Therapeutics News
Most Popular Chelsea Therapeutics Story
Chelsea shares nosedive on FDA's questions about key drug
Chelsea Therapeutics ($CHTP) CEO Simon Pedder sat on the hot seat this morning after his company's update on an ongoing FDA review of its lead drug Northera sparked concerns among some investors and Read more...
Latest Headlines
- February 13, 2012
- September 20, 2010
- November 3, 2009
- September 25, 2009
- September 24, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
